AMGN vs GLRE · P/E 24, rev $10.05B vs P/E 10, rev $327.1M
Amgen Inc (AMGN) versus Greenlight Capital Re Ltd (GLRE) — a side-by-side from cached financials, not a winner call.
Amgen Inc (AMGN) is a drug manufacturers - general company listed on US.
Greenlight Capital Re Ltd (GLRE) is a insurance - reinsurance company listed on US.
Latest reported AMGN revenue for 2026-06-30 was $10.05B. Net income was $2.38B. Revenue was up 16.7% from 2026-03-31 to 2026-06-30. AMGN currently screens at market cap $188.67B and trailing P/E 24.3.
Latest reported GLRE revenue for 2026-06-30 was $327.1M. Net income was $6.2M. Revenue was up 72.5% from 2026-03-31 to 2026-06-30. GLRE currently screens at market cap $478.2M and trailing P/E 10.5.
AMGN currently screens at market cap $188.67B and trailing P/E 24.3. GLRE currently screens at market cap $478.2M and trailing P/E 10.5.
Not investment advice. Open the AMGN and GLRE stock pages for the full models.
Not investment advice.